麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

美國MDxHealth  
MDxHealth是一家分子診斷公司，開發和銷售先進的測試為癌癥患者評估和個性化的治療。

申請專利的DNA甲基化平臺和生物標志物，我們幫助解決龐大且不斷增長的未滿足的醫療需求，為更好的癌癥診斷和治療的信息。

MDxHealth是一個公開上市的公司在紐約泛歐交易所集團（在紐約證券交易所，紐約證券交易所）代號“MDXH”布魯塞爾和阿姆斯特丹的市場交易。

MDxHealth（原名Oncomethylome Sciences公司）成立于2003年，總部設在比利時。其美國總部位于北卡羅來納州達勒姆。

MDxHealth自身或與制藥公司合作開發分子診斷產品。其部分產品已經商業化和公司的其他產品有廣泛的管道為主要癌癥的跡象。

MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients.

Applying our patented DNA methylation platform and biomarkers, we help address a large and growing unmet medical need for better cancer diagnosis and treatment information.

MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) markets of Brussels and Amsterdam under the ticker symbol "MDXH".

MDxHealth (formerly OncoMethylome Sciences) was established in 2003 and is headquartered in Belgium. Its US headquarters is located in Durham, NC.

MDxHealth develops molecular diagnostic products on its own or in partnership with pharmaceutical companies. Some of its products are already commercialized and the company has a broad pipeline of other products for major cancer indications.